A clinical trial of norethisterone oenanthate (Norigest) injected every two months

A clinical trial was carried out in which Norigest (200 mg norethisterone oenanthate) was administered by intramuscular injection every 56 days into 383 women studied for 5,521 woman-months of use. No pregnancies occurred. Continuation rates at the end of one, two and three years were 76.6%, 63.7% a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Contraception (Stoneham) 1982-04, Vol.25 (4), p.333-343
Hauptverfasser:	Howard, G., Blair, M., Chen, J.K., Fotherby, K., Muggeridge, J., Elder, M.G., Bye, P.G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Amenorrhea - chemically induced Blood Pressure - drug effects Body Weight - drug effects Clinical Trials as Topic Contraceptive Agents, Female - administration & dosage Drug Administration Schedule Female Humans Injections, Intramuscular Menstruation - drug effects Norethindrone - administration & dosage Norethindrone - analogs & derivatives Norethindrone - pharmacology Population
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!